Invivyd (IVVD) CFO awarded 625,000 stock options vesting over three years

Rhea-AI Filing Summary

Invivyd, Inc.’s Chief Financial Officer William E. Duke received a new stock option grant. On January 29, 2026, he was awarded options to purchase 625,000 shares of Invivyd common stock at an exercise price of $1.85 per share.

The options vest over three years, with 1/36th of the total vesting in substantially equal monthly installments starting one month after the grant date, contingent on his continuous service with the company.

Insights

Equity Compensation Analyst

CFO granted 625,000 stock options vesting monthly over three years.

The Chief Financial Officer of Invivyd, Inc., William E. Duke, was granted stock options for 625,000 shares at an exercise price of $1.85 per share. The transaction is coded as an acquisition of derivative securities and reflects a typical equity compensation award for a senior executive.

The option vests over three years in 36 substantially equal monthly installments beginning one month after January 29, 2026, conditioned on continued service. This structure is designed to align the executive’s incentives with longer-term company performance by requiring ongoing employment for full vesting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duke William E.

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CT 06510

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.85	01/29/2026		A		625,000		(1)	01/28/2036	Common Stock	625,000	$0.00	625,000	D

Explanation of Responses:

1. This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of January 29, 2026, subject to the Reporting Person's continuous service as of each vesting date.

	/s/ Jill Andersen attorney-in-fact for William E. Duke	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Invivyd (IVVD) disclose about CFO William Duke’s new stock options?

Invivyd reported that CFO William E. Duke received stock options for 625,000 shares at an exercise price of $1.85 per share. The award is recorded as an acquisition of derivative securities held directly by him, reflecting equity-based executive compensation.

How many Invivyd (IVVD) shares are covered by the CFO’s new option grant?

The new option grant to Invivyd’s CFO covers 625,000 shares of common stock. These options give him the right to buy that number of shares at the specified exercise price if and when they vest and are exercised.

What is the exercise price of the stock options granted to Invivyd’s CFO?

The stock options granted to Invivyd’s CFO have an exercise price of $1.85 per share. This means he can purchase Invivyd common stock at $1.85, once individual option portions have vested and he chooses to exercise them.

How do the Invivyd (IVVD) CFO stock options vest over time?

The CFO’s stock options vest over a three-year period. Specifically, 1/36th of the total 625,000 options vests in substantially equal monthly installments starting one month after the January 29, 2026 grant date, subject to his continuous service.

When do the Invivyd CFO’s stock options expire if unexercised?

The CFO’s stock options are scheduled to expire on January 28, 2036, if not exercised earlier. This expiration date sets a long-term window during which vested options can be exercised, subject to applicable company and regulatory requirements.

Is the Invivyd CFO’s new stock option grant a direct or indirect holding?

The filing classifies the CFO’s new stock option grant as held directly. After the reported transaction, he beneficially owns 625,000 derivative securities (stock options), with no separate entity or trust reported in connection with this particular award.